Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes-Reference-Cited by-同舟云学术

Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes

Published:2021-06-01 Issue:9 Volume:238 Page:2503-2514
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Babalonis Shanna^ORCID,Comer Sandra D.,Jones Jermaine D.,Nuzzo Paul,Lofwall Michelle R.,Manubay Jeanne,Hatton Kevin W.,Whittington Robert A.,Walsh Sharon L.

Funder

U.S. Food and Drug Administration

National Center for Advancing Translational Sciences

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s00213-021-05872-1.pdf

Reference60 articles.

1. Ambruzs JM, Serrell PB, Rahim N, Larsen CP (2014) Thrombotic microangiopathy and acute kidney injury associated with intravenous abuse of an oral extended-release formulation of oxymorphone hydrochloride: kidney biopsy findings and report of 3 cases. Am J Kidney Dis 63:1022–1026

2. Appleton JC (1960) Clinical evaluation and observation of 14-hydroxydihydromorphinone (Numorphan). Anesth Analg 39:505–510

3. Aqua K, Gimbel JS, Singla N, Ma T, Ahdieh H, Kerwin R (2007) Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial. Clin Ther 29:1000–1012

4. Babalonis S, Lofwall MR, Nuzzo PA, Walsh SL (2016) Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans. Addict Biol 21:146–158

5. Ballinger GA (2004) Using generalized estimating equations for longitudinal data analysis. Organ Res Methods 7:127–150

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The influence of drug class on reward in substance use disorders;Pharmacology Biochemistry and Behavior;2024-07

2. Strain and sex-related behavioral variability of oxycodone dependence in rats;Neuropharmacology;2023-10

3. Hydrocodone, Oxycodone, and Morphine Metabolism and Drug–Drug Interactions;Journal of Pharmacology and Experimental Therapeutics;2023-09-07

4. Endogenous opiates and behavior: 2021;Peptides;2023-06

5. A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population;Clinical Drug Investigation;2023-03